[HTML] nih.gov

[HTML][HTML] Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy

SA Toll, HN Tran, J Cotter, AR Judkins, B Tamrazi… - Oncotarget, 2019 - ncbi.nlm.nih.gov
Outcomes for children with high-grade gliomas (HGG) remain dismal despite aggressive
treatment strategies. The use of targeted therapy for BRAF V600E mutated malignancies …
被引用次数：53 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy

SA Toll, HN Tran, J Cotter, AR Judkins, B Tamrazi… - Clinical … - pdfs.semanticscholar.org
Outcomes for children with high-grade gliomas (HGG) remain dismal despite aggressive
treatment strategies. The use of targeted therapy for BRAFV600E mutated malignancies …
[PDF] archive.org

[PDF][PDF] Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy

SA Toll, HN Tran, J Cotter, AR Judkins, B Tamrazi… - Clinical trials - scholar.archive.org
Outcomes for children with high-grade gliomas (HGG) remain dismal despite aggressive
treatment strategies. The use of targeted therapy for BRAFV600E mutated malignancies …
[HTML] oncotarget.com

[HTML][HTML] Sustained response of three pediatric BRAF V600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy

SA Toll, HN Tran, J Cotter, AR Judkins, B Tamrazi… - Oncotarget, 2019 - oncotarget.com
Sustained response of three pediatric BRAF V600E mutated high-grade gliomas to combined
BRAF and MEK inhibitor therapy | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget …

Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy

SA Toll, HN Tran, J Cotter, AR Judkins… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Outcomes for children with high-grade gliomas (HGG) remain dismal despite aggressive
treatment strategies. The use of targeted therapy for BRAF V600E mutated malignancies …

[引用][C] Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy

SA Toll, HN Tran, J Cotter, AR Judkins, B Tamrazi… - Oncotarget, 2019 - cir.nii.ac.jp
Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined
BRAF and MEK inhibitor therapy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.

SA Toll, HN Tran, J Cotter, AR Judkins, B Tamrazi… - Oncotarget, 2019 - europepmc.org
Outcomes for children with high-grade gliomas (HGG) remain dismal despite aggressive
treatment strategies. The use of targeted therapy for BRAF V600E mutated malignancies …

Sustained response of three pediatric BRAF V600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy

SA Toll, HN Tran, J Cotter, AR Judkins, B Tamrazi… - Oncotarget, 2019 - oncotarget.com
Sustained response of three pediatric BRAF V600E mutated high-grade gliomas to combined
BRAF and MEK inhibitor therapy | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget …

Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.

SA Toll, HN Tran, J Cotter, AR Judkins, B Tamrazi… - Oncotarget, 2019 - europepmc.org
Outcomes for children with high-grade gliomas (HGG) remain dismal despite aggressive
treatment strategies. The use of targeted therapy for BRAF V600E mutated malignancies …